Ordering
Available Variants10 mg
CHA.19844-10mg
Price
€507.20
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
10 mg | CHA.19844-10mg | €507.20 |
phyproof® Reference Substance
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C20H20O5 |
|---|---|
| CAS Number | 68682-02-0 |
| Molecular Weight | 340.37 |
| NACRES | NA.24 |
| UNSPSC Code | 41116107 |
| Beilstein/REAXYS Number | 5611472 |
| MDL number | MFCD21364781 |
Safety Information Handling visibility
| pictograms |
GHS07
 GHS07
|
|---|---|
| signalword | Warning |
| hcodes | H302 + H312 + H332 |
| pcodes | P280 - P301 + P312 + P330 - P302 + P352 + P312 - P304 + P340 + P312 |
| Hazard Classifications | Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral |
| Storage Class | 11 - Combustible Solids |
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
8-Prenylnaringenin, with the CAS number 68682-02-0, is a prenylated flavonoid derived from hops, exhibiting a range of biological activities. This compound has been extensively studied for its potential health benefits, including its estrogenic and anti-estrogenic properties, which may contribute to its effects on bone health and menopausal symptoms. Additionally, 8-prenylnaringenin has been shown to possess antioxidant and anti-inflammatory activities, suggesting potential applications in the prevention and treatment of various diseases. Its ability to interact with estrogen receptors and influence hormone-dependent pathways has sparked interest in its potential use as a therapeutic agent, particularly in the context of hormone-related disorders. Further research is needed to fully elucidate the mechanisms of action and potential therapeutic applications of 8-prenylnaringenin.
